KK-5101

N/A

Report date: 2025/01/15 20:00:32

NME

Base Information

Drug NameKK-5101

Drug Alias NameKK-5101

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsTEK receptor tyrosine kinase antagonistsNerve growth factor receptor Trk-A antagonists

TargetsFibroblast growth factor receptor 4Nerve growth factor receptor Trk-ATEK receptor tyrosine kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKorea Institute Of Science And Technology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKorea Institute Of Science And Technology

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A